The criteria developed in this way also received cross-sectional validation.
The real advance of this approach has been to come up with criteria combining clinical manifestations with genotypes, with a new emphasis on molecular analysis, in trying to clarify these conditions.
Larry Beresford is a medical journalist in Oakland, Calif.
- Gattorno M, Hofer M, Federici S, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019 Aug; 78(8):1025–1032.
- De Benedetti F, Gattorno M, Anton J, et al. Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. N Engl J Med. 2018 May; 378(20):1908–1919.